Literature DB >> 3878585

Changes in red cell deformability associated with anaesthesia and cardiopulmonary bypass in open-heart surgery.

T Hirayama, H Yamaguchi, M Allers, D Roberts, G William-Olsson.   

Abstract

Red cell deformability was observed during open-heart surgery in 59 patients. Deformability, assessed with a standard microfiltration method, was expressed as red cell filtration rate (RFR) in microliter/s. The mean preoperative value, 38.9 +/- 1.0 microliter/s, showed a generally falling tendency. The first significant decrease in mean RFR (by 18%) followed induction of general anaesthesia, and the second (by 15%) was seen 60 min after the start of cardiopulmonary bypass (CPB). The major decrease in RFR during CPB was found at the end of bypass, when it was reduced to 62% of the pre-CPB value. The percentage RFR reduction at the end of CPB showed significant correlation with 1) CPB duration (r = 0.49), 2) oxygen flow rate index (OFRI), i.e. flow/min in the bubble oxygenator/m2 bsa (r = 0.38), and 3) blood flow rate index (BFRI), i.e. average volume of blood pumped through the heart-lung machine/min CPB time/m2 bsa (r = 0.51).

Entities:  

Mesh:

Year:  1985        PMID: 3878585     DOI: 10.3109/14017438509102728

Source DB:  PubMed          Journal:  Scand J Thorac Cardiovasc Surg        ISSN: 0036-5580


  4 in total

Review 1.  The clinical importance of erythrocyte deformability, a hemorrheological parameter.

Authors:  F C Mokken; M Kedaria; C P Henny; M R Hardeman; A W Gelb
Journal:  Ann Hematol       Date:  1992-03       Impact factor: 3.673

2.  Impaired red blood cell deformability after transfusion of stored allogeneic blood but not autologous salvaged blood in cardiac surgery patients.

Authors:  Osman N Salaria; Viachaslau M Barodka; Charles W Hogue; Dan E Berkowitz; Paul M Ness; Jack O Wasey; Steven M Frank
Journal:  Anesth Analg       Date:  2014-06       Impact factor: 5.108

3.  Trilinolein improves erythrocyte deformability during cardiopulmonary bypass.

Authors:  S K Tsai; P Chan; T Y Lee; J M Yung; C Y Hong
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

4.  Sarcoidosis and acute myeloid leukaemia.

Authors:  E A Murphy; J A Murphy; R Jackson; R D Sturrock
Journal:  J R Soc Med       Date:  1991-06       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.